Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Clarassance, Inc.
With
National Heart, Lung, and Blood Institute (NHLBI)
Age
0–0
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Newborn infants were considered for the study if the following criteria were met:
Age \< 24 hours;
Birthweight between 700 and 1,300 grams;
Gestational age greater than or equal to 24 weeks;
Diagnosis of neonatal RDS based on clinical and radiographic criteria;
Requiring intubation and mechanical ventilation for treatment of RDS;
Received at least one dose of surfactant 100 mg/kg (Survanta; Ross Laboratories);
Written informed consent from the infant's parent or legal guardian prior to enrollment of the patient and agrees to all study-related procedures and evaluations, including those required after hospital discharge.
You may not be if
Major congenital abnormalities (chromosomal, genetic, cardiac, pulmonary, or renal);
Clareo Health | Safety, Pk and Anti-inflammatory Effects of CC10 Protein in Premature Infants With Respiratory Distress Syndrome (RDS)
